These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 485389)

  • 1. [A new therapeutic possibility of abortion in 2d trimester using intravenous administration of sulprostone].
    Schmidt-Gollwitzer K; Schüssler B; Schmidt-Gollwitzer M
    Arch Gynecol; 1979 Jul; 228(1-4):402-3. PubMed ID: 485389
    [No Abstract]   [Full Text] [Related]  

  • 2. Termination of normal and pathological pregnancy with Sulprostone.
    Fischer Z; Chwalisz K; Michałkiewicz W
    Acta Chir Hung; 1986; 27(3):151-6. PubMed ID: 3825407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Induction of first and second-trimester abortion by the extra-amniotic administration of a prostaglandin E2-derivate (author's transl)].
    Kunz J; Kunz-Padrutt M; Bänninger U; Reich P; Keller PJ
    Geburtshilfe Frauenheilkd; 1979 Sep; 39(9):798-808. PubMed ID: 510909
    [No Abstract]   [Full Text] [Related]  

  • 4. [Prostaglandins for the termination of pathological pregnancies in the 2d trimester].
    Gruber W
    Wien Klin Wochenschr; 1982 Oct; 94(20):558-60. PubMed ID: 6963074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Termination of pregnancy and evacuation of the uterine contents in the second trimester. Use of a prostaglandin E2 analog: sulprostone].
    Barrat J; Cabrol D; Chouraqui A; Crépin G; Dumez Y; Hacker R; Henrion R; Magnin G; Soutoul JH; Sureau C
    J Gynecol Obstet Biol Reprod (Paris); 1987; 16(1):93-9. PubMed ID: 3584870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical experience with sulprostone (author's transl)].
    Brabec W; Dapunt O; Bichler A
    Wien Klin Wochenschr; 1981 Mar; 93(6):193-7. PubMed ID: 7281695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Priming of the cervix with prostaglandins in the first and second trimester].
    Brabec W
    Wien Klin Wochenschr; 1982 Oct; 94(20):554-8. PubMed ID: 7168176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of abortion with sulprostone, a uteroselective prostaglandin E2 derivative: intramuscular route of application.
    Schmidt-Gollwitzer K; Hoebich D; Hardt W; Schuessler B; Schmidt-Gollwitzer M
    Int J Fertil; 1981; 26(2):86-93. PubMed ID: 6114070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Use of prostaglandins in pregnancy termination in the 1st and 2d trimester].
    Rath W
    Wien Klin Wochenschr; 1987 Nov; 99(21):741-51. PubMed ID: 3321720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Sulprostone, a new prostaglandin E2 derivative (author's transl)].
    Schüssler B; Schmidt-Gollwitzer K; Schmidt-Gollwitzer M
    Dtsch Med Wochenschr; 1979 Nov; 104(48):1697-701. PubMed ID: 520164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [1st experiences with abortion induction using sulprostone, a prostaglandin E2 derivative].
    Gethmann U; Oberheuser F
    Arch Gynecol; 1979 Jul; 228(1-4):400-1. PubMed ID: 485388
    [No Abstract]   [Full Text] [Related]  

  • 12. [Dinoprostone or sulprostone. Comparison of 2 analogs of prostaglandin for the interruption of pregnancy in the 2nd trimester].
    Bourrit B; Graff P
    J Gynecol Obstet Biol Reprod (Paris); 1984; 13(1):87-90. PubMed ID: 6586818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Midtrimester termination of pregnancy using intravaginal gemeprost (16, 16 dimethyl-trans delta 2 PGE1 methyl ester, cervagem).
    Nair GV; Hii HC; Prasad RN; Kottegoda SR
    Singapore Med J; 1985 Apr; 26(2):199-202. PubMed ID: 4035402
    [No Abstract]   [Full Text] [Related]  

  • 14. [Sulprostone, an uterospecific prostaglandin E2 derivative. Significance for abortion with special reference to various administration forms].
    Schmidt-Gollwitzer M; Schüssler B; Schmidt-Gollwitzer K
    Arch Gynecol; 1979 Jul; 228(1-4):403. PubMed ID: 485390
    [No Abstract]   [Full Text] [Related]  

  • 15. [Use of a new synthetic prostaglandin (sulprostone) in various obstetrical conditions].
    Melis GB; Fruzzetti F; Paoletti AM; Strigini F; Baisi F; Gargiulo T; Pallotti A; Solla E; Sesselego G; Fioretti P
    Minerva Ginecol; 1982 Mar; 34(3):183-90. PubMed ID: 7045735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Use of sulprostone for cervical dilation in nulliparas during 1st trimester abortions].
    Giannone R; Poli M; Bernardi F; Ferrari E
    Minerva Ginecol; 1988 Sep; 40(9):553-5. PubMed ID: 3222011
    [No Abstract]   [Full Text] [Related]  

  • 17. [1st clinical experiences with prostaglandin E derivative sulprostone in extraamnial abortion induction].
    Briel RC; Lippert T; Kidess E; Roemer VM
    Arch Gynecol; 1979 Jul; 228(1-4):425. PubMed ID: 485413
    [No Abstract]   [Full Text] [Related]  

  • 18. [Cervix ripening and labor induction in therapeutic abortion in the middle and late 2d trimester using intracervical and extra-amniotic prostaglandin gel administration].
    Rath W; Ulbrich R; Kuhn W
    Wien Klin Wochenschr; 1985 May; 97(11):486-93. PubMed ID: 3859953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Intramural-intrauterine administration of prostaglandin E2 derivative for abortion induction in semi-hospitalized care in the operating room].
    Wiechell H
    Arch Gynecol; 1979 Jul; 228(1-4):409-10. PubMed ID: 485396
    [No Abstract]   [Full Text] [Related]  

  • 20. [Expulsion of arrested pregnancy product in the 2d trimester using a prostaglandin E1 analog administered intravaginally. Apropos of 12 cases].
    Lehair J; Lemarie P; Helleringer M; Manini P
    Rev Fr Gynecol Obstet; 1989 Jan; 84(1):19-23. PubMed ID: 2928658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.